Anxiolytic development candidate selected by Dainippon based on promising pharmacological profile April 4, 2000
Binding and neuroprotective studies with SM-31900 indicate potential in epilepsy, cerebral ischemia April 3, 2000
NeoTherapeutics commences worldwide clinical trial of Neotrofin as Alzheimer's treatment April 3, 2000
RSS